University of North Carolina at Chapel Hill(x)
The University of North Carolina at Chapel Hill is the nation’s oldest state university, with a rich history of more than two centuries.
Research: An Economic Engine
* Expenditures resulting from research funding at UNC-Chapel Hill cycle through the state and local economies, transforming federal funds into revenue for North Carolina residents and businesses.
* Using the U.S. government multiplier of 1.7, Carolina’s $610.7 million in research funding generated approximately $1.04 billion in economic impact.
Creating New Jobs
Applying their inventions and their know-how for economic growth, current and former UNC-Chapel Hill faculty, staff, and students have helped create many new companies in the recent past, employing more than 300 people. These companies represent a rich pipeline of research and innovation that generates 120 invention reports each year.
posted by University of North Carolina at Chapel Hill
on 06/30/2008
in Diagnostic, Environment
Human fecal wastes harbor viral pathogens that are major infectious disease risks. This simple, rapid, inexpensive and portable water quality monitoring test is an alternative to bacterial fecal i...
posted by University of North Carolina at Chapel Hill
on 09/10/2007
in Computer Software
“The Emergency Medical Text Processor (EMT-P) is a software system that cleans emergency department chief complaint (CC) text (e.g., chst pn, CP, c/p, chest pai, chert pain, chest/abd pain, c...
posted by University of North Carolina at Chapel Hill
on 08/14/2006
in Diagnostic, Therapeutic, Chemicals, Biomedical, Drug Discovery
In Haemophilus ducreyi (H. ducreyi), DsrA plays a role in the pathogenesis of chancroid and as a virulence factor. Serum-susceptible DsrA mutant strains may make excellent vaccine candidates.
posted by University of North Carolina at Chapel Hill
on 08/14/2006
in Biomedical, Genomics/Genetics, Proteomics
A method for identifying biologically significant peptide-DNA binding interactions and sequence-specific DNA-binding peptides in vivo using combinatorial oligonucleotide libraries.
posted by University of North Carolina at Chapel Hill
on 08/14/2006
in Therapeutic, Biomedical, Drug Discovery, Genomics/Genetics, Proteomics
Novel heparin cofactor II mutants with hyperactive thrombin inhibitory activity.
posted by University of North Carolina at Chapel Hill
on 08/14/2006
in Therapeutic, Biomedical, Drug Discovery
Lactoferrin can be used to regulate blood coagulation by inhibiting and/or regulating anticoagulant activity, including the neutralization of heparin.
posted by University of North Carolina at Chapel Hill
on 08/14/2006
in Process/Procedure, Biomedical, Gene Therapy
Improved packaging of rAAV vectors by reduction in Rep protein toxicity.
posted by University of North Carolina at Chapel Hill
on 08/14/2006
in Process/Procedure, Biomedical, Genomics/Genetics
Genetic engineering approach to reducing recombination events in RNA viruses and providing for more stable attenuated vaccines.
posted by University of North Carolina at Chapel Hill
on 08/14/2006
in Process/Procedure, Therapeutic, Biomedical
Methods for the stabilization of cellular structures with chemicalcross-linkers and lyophilizations in the preparation of red blood cells for long-term storage.
posted by University of North Carolina at Chapel Hill
on 08/11/2006
in Process/Procedure, Biomedical, Drug Screening
A method of screening for compounds which bind to and modulate the activity and/or formation of pathological EGFR-ERBB heterodimers without inhibiting normal receptor function.
